Discovery of a Novel Superpotent and Selective Melanocortin-4 Receptor Antagonist (HS024): Evaluation in Vitro and in Vivo**This work was supported by grants from the Swedish Medical Research Council (04X-05957), the Swedish Society for Medical Research, and the Estonian Science Foundation (Grant 3267); the Ants ja Maria Silvere ning Sigfried Panti Mälestusstipendium Foundation (to A.K.); and the Swedish Institute (to I.M.).
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Several novel cyclic MSH analogs were synthesized, and their binding properties were tested on cells transiently expressing the human melanocortin-1 (MC1), MC3, MC4, and MC5 receptors. We discovered a novel substance (HS024) that showed about 20-fold selectivity and very high affinity (Ki = 0.29 nM) for the MC4 receptor. HS024 (cyclic [AcCys3,Nle4,Arg5,D-Nal7,Cys-NH2(11)]alpha-MSH-(3-11)) has a 29-membered atom ring structure that includes an Arg in position 5. HS024 was found to antagonize an alphaMSH-induced cAMP response in cells expressing the human MC1, MC3, MC4, and MC5 receptor DNAs. HS024 also caused a dose-dependent increase in food intake, with a maximum response (4-fold increase) at a 1-nmol dose injected intracerebroventricularly in free feeding rats. We also tested SHU9119, a previously described nonselective MC receptor antagonist, and found HS024 and SHU9119 to have similar potencies for increasing food intake, although SHU9119 appeared to induce more serious side-effects. HS024 increased the food intake of free feeding rats to levels comparable to those in food-deprived rats, indicating that blockade of the MC4 receptor is a highly effective way to increase feeding. Moreover, we tested the effects of intracerebroventricular injections of HS024 in elevated plus-maze and open-field experiments on rats. In these tests, HS024 did not appear to affect emotionality or locomotor activity, suggesting that the MC4 receptor does not mediate the anxiogenic-like and locomotor effects related to the melanocortic peptides.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat
Pellow, S., Chopin, P., File, S. E., & Briley, M. (1985) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(85)90031-7 · Cited by 5,822
Sakurai, T., Amemiya, A., Ishii, M., Matsuzaki, I., Chemelli, R. M., Tanaka, H., Williams, S. C., Richardson, J. A., Kozlowski, G. P., Wilson, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)80949-6 · Cited by 5,501
The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity
de Lecea, L., Kilduff, T. S., Peyron, C., Gao, X.-B., Foye, P. E., Danielson, P. E., Fukuhara, C., Battenberg, E. L. F., Gautvik, V. T., Bartlett, F. S., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.322 · Cited by 3,878
Targeted disruption of the melanocortin-4 receptor results in obesity in mice
Huszar, D., Lynch, C. A., Fairchild-Huntress, V., Dunmore, J. H., Fang, Q., Berkemeier, L. R., Gu, W., Kesterson, R. A., Boston, B. A., Cone, R. D., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)81865-6 · Cited by 3,030
The cloning of a family of genes that encode the melanocortin receptors
Mountjoy, K. G., Robbins, L. S., Mortrud, M. T., & Cone, R. D. (1992) · Science · doi:10.1126/science.1325670 · Cited by 1,635
Dunn, A. J., & Berridge, C. W. (1990) · Brain Research Reviews · doi:10.1016/0165-0173(90)90012-d · Cited by 1,352
Heinrichs, S. C., Menzaghi, F., Pich, E. M., Baldwin, H. A., Rassnick, S., Britton, K. T., & Koob, G. F. (1994) · Neuropsychopharmacology · doi:10.1038/sj.npp.1380104 · Cited by 143
Research works printed but not linked: 41
- Chhajlani, 1992, Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA., FEBS Lett, 309, 417, 10.1016/0014-5793(92)80820-7 · DOI · Paper page
- Gantz, 1993, Molecular cloning of a novel melanocortin receptor., J Biol Chem, 268, 8246, 10.1016/S0021-9258(18)53088-X · DOI · Paper page
- Gantz, 1993, Molecular cloning, expression, and gene localization of a fourth melanocortin receptor., J Biol Chem, 268, 15174, 10.1016/S0021-9258(18)82452-8 · DOI · Paper page
- Chhajlani, 1993, Molecular cloning of a novel human melanocortin receptor., Biochem Biophys Res Commun, 195, 866, 10.1006/bbrc.1993.2125 · DOI · Paper page
- Cone, 1996, The melanocortin receptors: agonists, antagonists, and the hormonal control of pigmentation., Recent Prog Horm Res, 51, 287
- Roselli-Rehfuss, 1993, Identification of a receptor for melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system., Proc Natl Acad Sci USA, 90, 8856, 10.1073/pnas.90.19.8856 · DOI · Paper page
- Mountjoy, 1994, Localization of the melanocortin-4 receptor (MC4-R) in endocrine and autonomic control circuits in the brain., Mol Endocrinol, 8, 1298
- Chen, 1997, Exocrine gland dysfunction in MC5-R-deficient mice: evidence for coordinated regulation of exocrine gland function by melanocortin peptides., Cell, 91, 789, 10.1016/S0092-8674(00)80467-5 · DOI · Paper page
- Schiöth, 1995, Characterisation of melanocortin receptor subtypes by radioligand binding analysis., Eur J Pharmacol, 288, 311, 10.1016/0922-4106(95)90043-8 · DOI
- Schiöth, 1996, Characterisation of melanocortin 4 receptor by radioligand binding analysis., Pharmacol Toxicol, 79, 161, 10.1111/j.1600-0773.1996.tb00261.x · DOI · Paper page
- Schiöth, 1996, Major pharmacological distinction of the ACTH receptor from the other melanocortic receptors., Life Sci, 59, 797, 10.1016/0024-3205(96)00370-0 · DOI · Paper page
- Hruby, 1995, Cyclic lactamα -melanotropin analogues of Ac-Nle4-cyclo(Asp5,d-Phe7,Lys10)α-melanocyte-stimulating hormone-(4–10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors., J Med Chem, 38, 3454, 10.1021/jm00018a005 · DOI · Paper page
- Schiöth, 1998, Discovery of novel melanocortin 4 receptor selective MSH analogues., Br J Pharmacol, 124, 75, 10.1038/sj.bjp.0701804 · DOI · Paper page
- Li, 1996, Melanocortin antagonists define two distinct pathways of cardiovascular control by α- andγ -melanocyte-stimulating hormones., J Neurosci, 16, 5182, 10.1523/JNEUROSCI.16-16-05182.1996 · DOI · Paper page
- Fan, 1997, Role of melanocortinergic neurons in feeding and the agouti obesity syndrome., Nature, 385, 165, 10.1038/385165a0 · DOI · Paper page
- Seeley, 1997, Melanocortin receptors in leptin effects., Nature, 390, 349, 10.1038/37016 · DOI · Paper page
- Kask, 1998, Selective antagonist for the melanocortin 4 receptor (HS014) increases food intake in free-feeding rats., Biochem Biophys Res Commun, 245, 90, 10.1006/bbrc.1998.8389 · DOI
- Kask, 1998, Evidence that orexigenic effects of melanocortin 4 receptor antagonist HS014 are mediated by neuropeptide Y., Biochem Biophys Res Commun, 248, 245, 10.1006/bbrc.1998.8961 · DOI
- Tagliaferro, 1982, Spillage behavior and thiamin deficiency in the rat., Physiol Behav, 28, 933, 10.1016/0031-9384(82)90217-7 · doi:10.1016/0031-9384(82)90217-7
- Gonzales, 1996, Behavioral effects of α-MSH and MCH after central administration in the female rat., Peptides, 17, 171, 10.1016/0196-9781(95)02092-6 · DOI · Paper page
- Panksepp, 1990, Modulation of separation distress by α-MSH., Peptides, 11, 647, 10.1016/0196-9781(90)90174-4 · doi:10.1016/0196-9781(90)90174-4
- Panksepp, 1990, Effects of ACTH(1–24) and ACTH/MSH-(4–10) on isolation-induced distress vocalization in domestic chicks., Peptides, 11, 915, 10.1016/0196-9781(90)90009-T · doi:10.1016/0196-9781(90)90009-t
- Corda, 1990, Proconflict effect of ACTH1–24: interaction with benzodiazepines., Pharmacol Biochem Behav, 36, 631, 10.1016/0091-3057(90)90267-L · doi:10.1016/0091-3057(90)90267-l
- Sawyer, 1980, [Nle4,d-Phe7]a-melanocyte stimulating hormone: a highly potent α-melanotropin with ultralong biological activity., Proc Natl Acad Sci USA, 77, 5754, 10.1073/pnas.77.10.5754 · DOI · Paper page
- Nordstedt, 1990, A modification of a protein-binding method for rapid quantification of cAMP in cell-culture supernatants and body fluid., Anal Chem, 189, 231
- Schiöth, 1997, Selectivity of cyclic [d-Phe7] and[ d-Nal7] substituted MSH analogues for the melanocortin receptors., Peptides, 18, 1009, 10.1016/S0196-9781(97)00079-X · DOI
- Kask, 1997, α-helical CRF9–41 prevents anxiogenic-like effect of NPY Y1 receptor antagonist BIBP3226 in rats., Neuroreport, 8, 3645, 10.1097/00001756-199711100-00044 · DOI · Paper page
- Kask, 1998, Anxiolytic-like effect of neuropeptide Y (NPY) and NPY13–36 microinjected into vicinity of locus coeruleus in rats., Brain Res, 788, 345, 10.1016/S0006-8993(98)00076-6 · DOI
- Broadhurst, 1975, The Maudsley reactive and nonreactive strains of rats: a survey., Behav Genet, 5, 299, 10.1007/BF01073201 · DOI · Paper page
- Knittel, 1983, Structure-activity studies of highly potent[ Cys4,Cys10]melanotropin analogues., J Med Chem, 28, 125, 10.1021/jm00356a002 · doi:10.1021/jm00356a002
- Sawyer, 1982, [half-Cys4, half-Cys10]-α-melanocyte stimulating hormone; a cyclic α-melanotropin exibiting superagonist biological activity., Proc Natl Acad Sci USA, 79, 1751, 10.1073/pnas.79.6.1751 · DOI · Paper page
- Al-Obeidi, 1989, Potent and prolonged acting cyclic lactam analogues ofα -melanotropin: design based on molecular dynamics., J Med Chem, 32, 2555, 10.1021/jm00132a010 · DOI · Paper page
- Schiöth, 1998, Selective properties of C- and N-terminals and core residues in the melanocortin stimulating hormone peptide for the melanocortin receptor subtypes., Eur J Pharmacol, 349, 359, 10.1016/S0014-2999(98)00212-X · DOI
- Jayawickreme, 1994, Discovery and structure-function analysis of a-melanocyte-stimulating hormone antagonists., J Biol Chem, 269, 29846, 10.1016/S0021-9258(18)43958-0 · DOI
- Quillan, 1996, Structure-based search for peptide ligands that cross-react with melanocortin receptors., Pharm Res, 13, 1624, 10.1023/A:1016424203457 · doi:10.1023/a:1016424203457
- Kask, 1998, Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226., Br J Pharmacol, 124, 1507, 10.1038/sj.bjp.0701969 · DOI · Paper page
- Morley, 1987, Effect of neuropeptide Y on ingestive behaviors in the rat, Am J Physiol, 252, R599
- Biro, 1993, Role of endogenous corticotropin-releasing factor in mediation of neuroendocrine and behavioral responses to cholecystokinin octapeptide sulfate ester in rats., Neuroendocrinology, 57, 340, 10.1159/000126377 · DOI · Paper page
- Heilig, 1988, Neuropeptide Y (NPY)-induced suppression of activity in the rat: evidence for NPY receptor heterogeneity and for interaction withα -adrenoceptors., Eur J Pharmacol, 157, 205, 10.1016/0014-2999(88)90384-6 · DOI
- Kim, 1997, Agouti regulation of intracellular calcium: role of melanocortin receptors, Am J Physiol, 272, E379
- Gross, 1993, A new experimental model of epilepsy based on the intraventricular injection of endothelin, J Cardiovasc Pharmacol, 22, S282, 10.1097/00005344-199322008-00074 · doi:10.1097/00005344-199322008-00074
Cited by
Interacting Appetite-Regulating Pathways in the Hypothalamic Regulation of Body Weight
Kalra, S. P. (1999) · Endocrine Reviews · doi:10.1210/er.20.1.68 · Cited by 1,554
Interacting Appetite-Regulating Pathways in the Hypothalamic Regulation of Body Weight*
Kalra, S. P., Dube, M. G., Pu, S., Xu, B., Horvath, T. L., & Kalra, P. S. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.1.0357 · Cited by 1,552
The Melanocortin-4 Receptor: Physiology, Pharmacology, and Pathophysiology
Tao, Y.-X. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0037 · Cited by 531
Targeting melanocortin receptors as a novel strategy to control inflammation
Catania, A., Gatti, S., Colombo, G., & Lipton, J. M. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.1.1 · Cited by 438
Baskin, D. G., Figlewicz Lattemann, D., Seeley, R. J., Woods, S. C., Porte, D., & Schwartz, M. W. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01974-5 · Cited by 398
Metadata
- Authors
- Kask, A., Mutulis, F., Muceniece, R., Pähkla, R., Mutule, I., Wikberg, J. E. S., Rägo, L., & Schiöth, H. B.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 1998-12-01
- Volume
- 139
- Issue
- 12
- Pages
- 5006-5014
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W1980392808
- Cited by
- 155
- References
- 7
- FWCI
- 4.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Discovery of a Novel Superpotent and Selective Melanocortin-4 Receptor Antagonist (HS024): Evaluation in Vitro and in Vivo**This work was supported by grants from the Swedish Medical Research Council (04X-05957), the Swedish Society for Medical Research, and the Estonian Science Foundation (Grant 3267); the Ants ja Maria Silvere ning Sigfried Panti Mälestusstipendium Foundation (to A.K.); and the Swedish Institute (to I.M.). https://app.cochat.ai/papers/10.1210/endo.139.12.6352
- The paper
- Kask, A., Mutulis, F., Muceniece, R., Pähkla, R., Mutule, I., Wikberg, J. E. S., Rägo, L., & Schiöth, H. B. (1998). Discovery of a Novel Superpotent and Selective Melanocortin-4 Receptor Antagonist (HS024): Evaluation in Vitro and in Vivo**This work was supported by grants from the Swedish Medical Research Council (04X-05957), the Swedish Society for Medical Research, and the Estonian Science Foundation (Grant 3267); the Ants ja Maria Silvere ning Sigfried Panti Mälestusstipendium Foundation (to A.K.); and the Swedish Institute (to I.M.). Endocrinology. https://doi.org/10.1210/endo.139.12.6352
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.